Clinical Trial Update: PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update on PfSPZ Vaccine exploring dose optimization with heterologous challenge in malaria-naïve adults completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria | Phase 2 | Status: COMPLETED